OMG and neuromyelitis optica: Subsequently, 1 nonkidney control patient diagnosed with neuromyelitis optica having autoantibodies directed against myelin oligodendrocyte glycoprotein was included, because this patient was treated with the same PP protocol as the FSGS patients mentioned above.